| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.52 | 0.0006 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-11 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-08 |